Editorial
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Feb 28, 2020; 8(1): 1-3
Published online Feb 28, 2020. doi: 10.13105/wjma.v8.i1.1
Is there still a role for sucralfate in the treatment of gastritis?
Simon R Bramhall, Moustafa M Mourad
Simon R Bramhall, Department of Surgery, The County Hospital, Hereford HR1 2ER, United Kingdom
Moustafa M Mourad, Worcester Royal Infirmary, Worcester WR4 0JB, United Kingdom
Author contributions: Bramhall SR, Mourad MM made the concept of manuscript, manuscript review and accuracy check; Bramhall SR wrote the manuscript.
Conflict-of-interest statement: The authors have nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Simon Bramhall, FRCS (Gen Surg), MD, Attending Doctor, Doctor, Surgeon, Department of Surgery, The County Hospital, Union Walk, Hereford HR1 2ER, United Kingdom. simon.bramhall@wvt.nhs.uk
Received: November 1, 2019
Peer-review started: November 1, 2019
First decision: November 22, 2019
Revised: December 3, 2019
Accepted: December 14, 2019
Article in press: December 14, 2019
Published online: February 28, 2020
Processing time: 118 Days and 22.6 Hours
Core Tip

Core tip: An endoscopic diagnosis of gastritis is commonly made. When patients have significant symptoms associated with this finding and no other explanation can be found for their symptoms the first line treatment tends to be with a proton pump inhibitor. The combination of a proton pump inhibitor and sucralfate can however, be useful in the treatment of these patients when conventional treatment has failed and symptoms are severe.